GYRE 8-K: SEC filing
Filed with the SEC on · accession 0001193125-26-449985
GYRE filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
Gyre Therapeutics, Inc. furnished a Form 8-K reporting its financial results for the three and nine months ended September 30, 2026, and made available an updated corporate presentation on its website.
Key details
✦ Ask GOAX AI about this filing — what it means for GYRE, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for GYRE?
Click hereFrequently asked questions
What did GYRE file with the SEC on Nov 5, 2026?
GYRE filed a 8-K (SEC filing). Gyre Therapeutics, Inc. furnished a Form 8-K reporting its financial results for the three and nine months ended September 30, 2026, and made available an updated corporate presentation on its website.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other GYRE SEC filings
- 8-K · Executive departureOct 22, 2026
- 8-K · SEC filingSep 1, 2026
- 8-K · SEC filingAug 26, 2026
- 10-Q · SEC filingAug 7, 2026
- 8-K · SEC filingAug 7, 2026
- EFFECT · SEC filingAug 3, 2026
- 8-K · Board changeJul 16, 2026
- 8-K · AcquisitionJul 15, 2026
- S-3 · Shelf registrationJul 13, 2026
- S-3 · Shelf registrationJun 23, 2026
Get alerts when GYRE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days